Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia. - Waldmann TA; Conlon KC; Stewart DM; Worthy TA; Janik JE; Fleisher TA; Albert PS; Figg WD; Spencer SD; Raffeld M; Decker JR; Goldman CK; et al. (Blood, 2013)